Koers Qianjiang Yongan Pharmaceutical Co., Ltd.
Aandelen
002365
CNE100000LZ9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,1 CNY | +2,90% | +3,05% | -27,40% |
Omzet 2022 | 1,46 mld. 202 mln. 188 mln. | Omzet 2023 | 973 mln. 134 mln. 125 mln. | Marktkapitalisatie | 2,88 mld. 398 mln. 371 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 140 mln. 19,32 mln. 18,04 mln. | Nettowinst (verlies) 2023 | -12 mln. -1,66 mln. -1,55 mln. | EV/omzet 2022 | 1,57 x |
Nettoliquiditeiten 2022 | 792 mln. 109 mln. 102 mln. | Nettoliquiditeiten 2023 | 946 mln. 131 mln. 122 mln. | EV/omzet 2023 | 1,99 x |
K/w-verhouding 2022 |
22
x | K/w-verhouding 2023 |
-234
x | Werknemers | 1.004 |
Dividendrendement 2022 |
0,95% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 66,44% |
1 dag | +2,90% | ||
1 week | +3,05% | ||
Lopende maand | -4,05% | ||
1 maand | -4,70% | ||
3 maanden | -16,27% | ||
6 maanden | -28,21% | ||
Lopend jaar | -27,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ren Gui Hong
CEO | Chief Executive Officer | 41 | 28-06-21 |
Yu Xi Wu
CHM | Chairman | 63 | 12-11-13 |
Sheng Jie Xiong
DFI | Director of Finance/CFO | 56 | 28-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yong Chen
FOU | Founder | 65 | 18-06-01 |
Yu Xi Wu
CHM | Chairman | 63 | 12-11-13 |
Hong Li Ding
BRD | Director/Board Member | 58 | 31-05-12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 7,1 | +2,90% | 2 787 600 |
23-04-24 | 6,9 | +2,99% | 2 700 166 |
22-04-24 | 6,7 | -0,45% | 2 588 366 |
19-04-24 | 6,73 | -1,46% | 2 815 816 |
18-04-24 | 6,83 | -0,87% | 3 264 766 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,40% | 289 mln. | |
+25,61% | 660 mld. | |
+25,87% | 562 mld. | |
-5,24% | 358 mld. | |
+16,49% | 322 mld. | |
+8,28% | 297 mld. | |
+7,09% | 219 mld. | |
-9,12% | 196 mld. | |
+5,01% | 199 mld. | |
-8,75% | 149 mld. |